BGLC
BioNexus Gene Lab Corp.
NASDAQ · Healthcare · Medical - Diagnostics & Research · MY
$1.41
−4.08%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.13x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.08x
- Net debt / EBITDA
- 0.42x
Liquidity & coverage
- Current ratio
- 6.08x
- Quick ratio
- 5.28x
- Cash ratio
- 4.33x
- Interest coverage
- -407.16x
- EBITDA / interest
- -383.57x
- Working capital
- $4.1M
Cash & dividend
- FCF / debt
- -4.38x
- Cash flow / debt
- -4.24x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026